Pneumonitis is a serious treatment-related side-effect of both radiation, immunotherapy and some chemotherapies. This episode of MesoTV includes discussion on diagnosis, treatment and the dilemma…
As Father’s Day approaches, many in the meso community will be honoring, and in some cases remembering, the fathers in their lives. In this spirit,…
The National Cancer Institute, part of the National Institutes of Health in Bethesda, Maryland, is working toward developing new protocols for improved treatment for peritoneal…
Immunotherapy may utilize the body’s own immune system to fight the cancer, but that does not mean that it comes free of side-effects. What are…
Dr. Melissa Johnson of the Sarah Cannon Cancer Center in Nashville, TN talks to us about a multi-center clinical trial utilizing engineered t-cell therapy similar…
The International Mesothelioma Interest Group (iMig) biannual meeting kicked off in earnest today with its 2021 virtual program. The conference was initially slated to take…
The Mesothelioma Applied Research Foundation is pleased to announce the addition of seven new members to its science advisory board (SAB). Madhavi Ganapathiraju, PhD – University of Pittsburgh Jonathan…
Bonnie Anderson is a 19-year mesothelioma survivor. She discusses her peritoneal mesothelioma diagnosis in 2002, her history with multiple cancers, and her family’s advocacy efforts…
In 2016, the Mesothelioma Applied Research Foundation funded a grant to Antonio Giordano, MD, PhD, director and founder of the Sbarro Health Research Organization at Temple University, to investigate how silencing…








